Literature DB >> 6772294

Current status of clinical particle radiotherapy at Lawrence Berkeley Laboratory.

J R Castro, J M Quivey, J T Lyman, G T Chen, T L Phillips, C A Tobias, E L Alpen.   

Abstract

Clinical experience with charged particle irradiation of human cancers has been underway at the University of California Lawrence Berkeley Laboratory. Over 150 patients have been irradiated with heavy charged particle beams including helium, carbon, neon, and argon ions. Pilot studies have included such tumor sites as glioma of the brain, carcinoma of the esophagus, carcinoma of the pancreas, carcinoma of the stomach, ocular melanoma, and carcinoma of the uterine cervix. Prospective studies are planned to investigate the improved dose localization potential (helium) and the enhanced biologic and physical dose potential (carbon, neon) in a controlled trial against the best available megavoltage irradiation techniques.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6772294     DOI: 10.1002/1097-0142(19800815)46:4<633::aid-cncr2820460402>3.0.co;2-o

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

1.  Intraoperative radiation therapy for patients with pancreatic carcinoma.

Authors:  W U Shipley; J E Tepper; A L Warshaw; E L Orlow
Journal:  World J Surg       Date:  1984-12       Impact factor: 3.352

2.  Two cases of orbital adenocarcinoma treated with heavy charged carbon particle irradiation.

Authors:  Aki Hirai; Atsushi Mizota; Seiichiro Mine; Jun-etsu Mizoe
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-01-26       Impact factor: 3.117

3.  Phase II trial of 5-fluorouracil, adriamycin and cisplatin (FAP) followed by radiation and 5-fluorouracil in locally advanced pancreatic cancer.

Authors:  D J Wagener; Q G van Hoesel; S H Yap; W J Hoogenraad; T Wobbes; S P Strijk
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

4.  Towards clinical evidence in particle therapy: ENLIGHT, PARTNER, ULICE and beyond.

Authors:  Stephanie E Combs; Manjit Djosanjh; Richad Pötter; Roberto Orrechia; Thomas Haberer; Marco Durante; Piero Fossati; Katia Parodi; Jacques Balosso; Ugo Amaldi; Michael Baumann; Jürgen Debus
Journal:  J Radiat Res       Date:  2013-07       Impact factor: 2.724

5.  Three discipline collaborative radiation therapy (3DCRT) special debate: The United States needs at least one carbon ion facility.

Authors:  Eleanor A Blakely; Bruce Faddegon; Christopher Tinkle; Charles Bloch; Michael Dominello; Robert J Griffin; Michael C Joiner; Jay Burmeister
Journal:  J Appl Clin Med Phys       Date:  2019-10-01       Impact factor: 2.243

Review 6.  Considerations for Upright Particle Therapy Patient Positioning and Associated Image Guidance.

Authors:  Lennart Volz; Yinxiangzi Sheng; Marco Durante; Christian Graeff
Journal:  Front Oncol       Date:  2022-07-29       Impact factor: 5.738

Review 7.  Treatment-integrated imaging, radiomics, and personalised radiotherapy: the future is at hand.

Authors:  Julian Malicki; Tomasz Piotrowski; Ferran Guedea; Marco Krengli
Journal:  Rep Pract Oncol Radiother       Date:  2022-09-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.